These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2021110)

  • 41. [Zidovudine in asymptomatic HIV infection].
    Bornkessel B
    Med Monatsschr Pharm; 1991 Aug; 14(8):250. PubMed ID: 1921844
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study.
    Meng TC; Fischl MA; Cheeseman SH; Spector SA; Resnick L; Boota A; Petrakis T; Wright B; Richman DD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):152-60. PubMed ID: 7834398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
    Peto TE
    AIDS; 1990; 4 Suppl 1():S187-91. PubMed ID: 2152565
    [No Abstract]   [Full Text] [Related]  

  • 44. Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
    Barzilai A; Sperling RS; Hyatt AC; Wedgwood JF; Reidenberg BE; Hodes DS
    Pediatr Infect Dis J; 1990 Dec; 9(12):931-3. PubMed ID: 2277754
    [No Abstract]   [Full Text] [Related]  

  • 45. Zidovudine approved for use in children.
    Pa Med; 1990 Jun; 93(6):20. PubMed ID: 2367131
    [No Abstract]   [Full Text] [Related]  

  • 46. Zidovudine monotherapy in pregnancy: is it state of the art?
    Taylor GP; O'Shea S; Mercey D; de Ruiter A
    HIV Med; 2009 Feb; 10(2):129-30; author reply 130-1. PubMed ID: 19200176
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 48. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
    Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
    An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chemotherapy of HIV].
    Belec L; Bledin M
    Rev Infirm; 1991 Dec; 41(20):44-8. PubMed ID: 1771362
    [No Abstract]   [Full Text] [Related]  

  • 51. More on zidovudine in asymptomatic HIV infection.
    Altman DG; Cuzick J; Peto J
    N Engl J Med; 1994 Jun; 330(24):1758-9. PubMed ID: 8190146
    [No Abstract]   [Full Text] [Related]  

  • 52. Early zidovudine and survival in HIV infection.
    Hirschel B
    N Engl J Med; 1992 Sep; 327(11):814; author reply 815-6. PubMed ID: 1501667
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of HIV infection--progress in perspective.
    Corey L; Fleming TR
    N Engl J Med; 1992 Feb; 326(7):484-6. PubMed ID: 1732776
    [No Abstract]   [Full Text] [Related]  

  • 54. NIH panel loosens zidovudine guidelines.
    McCarthy M
    Lancet; 1993 Jul; 342(8863):104-5. PubMed ID: 8100866
    [No Abstract]   [Full Text] [Related]  

  • 55. Zidovudine effective in all ethnic groups.
    Nurs RSA; 1992; 7(11-12):53. PubMed ID: 1289718
    [No Abstract]   [Full Text] [Related]  

  • 56. HIV infection in the elderly.
    Boudes P
    Compr Ther; 1991 Sep; 17(9):39-42. PubMed ID: 1769199
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum beta 2-M in asymptomatic HIV-infected patients treated with zidovudine.
    Mastroianni CM; Paoletti F; Vullo V; Delia S; Sorice F
    AIDS; 1990 Dec; 4(12):1297. PubMed ID: 2088409
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of mildly symptomatic human immunodeficiency virus (HIV) infection.
    Hamilton JD; Simberkoff MS; Hartigan P
    Ann Intern Med; 1990 Oct; 113(8):635-6. PubMed ID: 2400172
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of zidovudine in HIV-infected children with lymphocytic interstitial pneumonitis.
    Principi N; Marchisio P; Massironi E; Plebani A; Careddu P; Cristina S; D'Arminio Monforte A
    AIDS; 1991 Apr; 5(4):468-9. PubMed ID: 2059391
    [No Abstract]   [Full Text] [Related]  

  • 60. The treatment of asymptomatic HIV infection: lessons from the zidovudine experience.
    Weller IV
    AIDS; 1989; 3 Suppl 1():S215-20. PubMed ID: 2514740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.